<DOC>
	<DOCNO>NCT00347035</DOCNO>
	<brief_summary>Purpose : To evaluate influence nonsteroidal anti-inflammatory indomethacin brimonidine intraocular pressure ( IOP ) lower effect . Methods : A randomized double-masked study carry . Patients medicate timolol maleate 0,5 % need complementary medication random allocate two group : ( ) brimonidine tartarate 0,15 % indomethacin 1 % ( b ) brimonidine tartarate placebo ( balanced saline solution ) . If patient â€™ eye eligible , allocate group . IOP measure two week , one month two month study begin . The mean IOP eye use analyzes , case two eligible eye . For statistical analyzes repeat measure analysis use .</brief_summary>
	<brief_title>INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE</brief_title>
	<detailed_description />
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>primary openangle glaucoma ocular hypertension patient follow criterion : 18 year age old , insufficient response monotherapy timolol maleate 0,5 % , adequate compliance followup treatment hypersensitivity eyedrop solution , insufficient compliance followup treatment , pregnancy childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>